285 related articles for article (PubMed ID: 4549691)
1. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
Woodruff MF; McBride WH; Dunbar N
Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
[TBL] [Abstract][Full Text] [Related]
2. Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.
Woodruff MF; Dunbar N
Br J Cancer; 1975 Jul; 32(1):34-41. PubMed ID: 1080671
[TBL] [Abstract][Full Text] [Related]
3. Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice.
James K; Willmott N; Milne I; McBride WH
J Natl Cancer Inst; 1976 May; 56(5):1035-40. PubMed ID: 825650
[TBL] [Abstract][Full Text] [Related]
4. The effect of Corynebacterium parvum on T cell dependent tumor regression.
McBride WH; Peters LJ; Mason KA; Barrow G
J Reticuloendothel Soc; 1980 Feb; 27(2):151-8. PubMed ID: 6965725
[No Abstract] [Full Text] [Related]
5. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
Hamilton DN; Bell PR
Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
[No Abstract] [Full Text] [Related]
6. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.
Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L
J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869
[No Abstract] [Full Text] [Related]
7. The mechanism of inhibition by Corynebacterium parvum of the growth of lung nodules from intravenously injected tumour cells.
Bomford R; Olivotto M
Int J Cancer; 1974 Aug; 14(2):226-35. PubMed ID: 4376512
[No Abstract] [Full Text] [Related]
8. [Effect of silica on the anti-tumour activity of "Corynebacterium parvum" (author's transl)].
Mazurek C; Stiffel C; Chalvet H; Biozzi G
Ann Immunol (Paris); 1979; 130(6):815-26. PubMed ID: 232975
[TBL] [Abstract][Full Text] [Related]
9. Enhancement and depression of the antibody response in mice caused by Corynebacterium parvum.
Warr GW; Sljivić VS
Clin Exp Immunol; 1974 Jul; 17(3):519-32. PubMed ID: 4157122
[No Abstract] [Full Text] [Related]
10. Possible mechanisms in the anti-tumour activity of C. parvum.
Cullen RT
Dev Biol Stand; 1977 Apr 13-15; 38():265-71. PubMed ID: 305375
[TBL] [Abstract][Full Text] [Related]
11. Increased phagocytic cell activity and anaemia in Corynebacterium parvum treated mice.
McBride WH; Jones JT; Weir DM
Br J Exp Pathol; 1974 Feb; 55(1):38-46. PubMed ID: 4835797
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
Moore K; McBride WH
Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
[TBL] [Abstract][Full Text] [Related]
13. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
Ghaffar A; Cullen RT
J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy and immunotherapy of diabetic and non-diabetic mice bearing fibrosarcoma.
Pavelić K; Hrsak I
Eur J Cancer (1965); 1980 Oct; 16(10):1297-301. PubMed ID: 7009161
[No Abstract] [Full Text] [Related]
15. Corynebacterium parvum-induced resistance to a methylcholanthrene fibrosarcoma.
Gupta JD; Morahan PS; Kaplan AM
J Reticuloendothel Soc; 1978 Jan; 23(1):1-9. PubMed ID: 627989
[No Abstract] [Full Text] [Related]
16. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
Milas L; Hunter N; Withers HR
Cancer Res; 1974 Mar; 34(3):613-20. PubMed ID: 4590922
[No Abstract] [Full Text] [Related]
17. The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum.
Watson SR; Sljivić VS
Clin Exp Immunol; 1976 Jan; 23(1):149-53. PubMed ID: 770033
[TBL] [Abstract][Full Text] [Related]
18. Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells.
Bomford R
Br J Cancer; 1975 Nov; 32(5):551-7. PubMed ID: 1082344
[TBL] [Abstract][Full Text] [Related]
19. A role for T lymphocytes in tumour inhibition and enhancement caused by systemic administration of Corynebacterium parvum.
Peters LJ; McBride WH; Mason KA; Milas L
J Reticuloendothel Soc; 1978 Jul; 24(1):9-18. PubMed ID: 308542
[No Abstract] [Full Text] [Related]
20. Antibody responses, antitumour antibodies and Ig class and subclass levels in C. parvum treated mice.
James K
Dev Biol Stand; 1977 Apr 13-15; 38():173-81. PubMed ID: 608503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
